Evercode BCR | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,442 results for “Evercode BCR”

Trials

View all 1641 →

Autoimmune Cytopenia and BcR Inhibitors

40 participants · First posted Mar 19, 2018

Nilotinib in PH+, BCR-, ABL+ CML Patients

109 participants · First posted Feb 17, 2012

Not yet recruiting

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

80 participants · First posted Dec 24, 2025

Drugs

View all 441 →

BCR-ABL(Theseus)

BCR-Abl inhibitor(Nanjing Sanhome Pharmaceutical)

ACTB-1011

Organizations

View all 24 →

OVERCOME

France

EVERMORE TRADING PTY LTD

Australia

Evercare Pharmaceutical Company Limited

Hong Kong, China

News

View all 336 →

Parse Biosciences Wins Patent Invalidation Case Against 10x Genomics in Single Cell Sequencing Dispute

Parse Biosciences Expands Global Single Cell Sequencing Access Through Strategic Service Provider Partnerships

Digital PCR Outperforms Standard RT-qPCR in Detecting Residual BCR::ABL1 in CML Patients, Enabling Better TKI Discontinuation Decisions

Page 1 of 245